Recognized as the original and leading annual forum for personalized medicine

Attracts recognized authorities and experts across healthcare and biotechnology sectors

Delivers the broadest and most up-to-date content across all facets of precision medicine in a collegial atmosphere.

Recognized as the original and leading annual forum for precision medicine

Attracts recognized authorities and experts across healthcare and biotechnology sectors

Delivers the broadest and most up-to-date content across all facets of precision medicine in a collegial atmosphere.

2009

Established

11,500

Attendees

1,700

Speakers

2,050

Companies

Conference Co-Hosts

“What does precision medicine look like in the real world, what is the state of the art, what are the next key developments, how do we scale it, what do we need to plan for, and what are the hurdles and issues we may encounter?”

Ralph Snyderman, M.D., PMWC 2017 Duke Program Co-Chair

Chancellor Emeritus, Duke University

“As a team we are bringing cross-functional stakeholders of this exciting field together to exchange ideas and the learnings gathered so far that can be translated into new winning strategies for the future of precision medicine as a cutting edge development in healthcare.”

Geoff Ginsburg, M.D., Ph.D., PMWC 2017 Duke Program Co-Chair

Director, Duke Center for Applied Genomics & Precision Medicine

Speakers

Robert M. Califf
Duke University

Francis S. Collins
National Institutes of Health (NIH)

Mark Levin
Third Rock Ventures

Janet Woodcock
FDA

Robert M. Califf
Duke University

Francis S. Collins
National Institutes of Health (NIH)

Mark Levin
Third Rock Ventures

See All

Session Themes

Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology

Session Chair: Fred Ashbury, Viviphi Ltd.

A Discussion on Increasing Patient Access To Investigational Drugs

Session Chair: Marty Tenenbaum, Cancer Commons

How Patients Can Advance Precision Medicine and Why You Should Care

Session Chair: Moira Quinn, Charlotte Center City Partners

Trends in Comprehensive Study and Biological Sample Management

Session Chair: Andrew Brooks, Bioprocessing Solutions Alliance

Automating Evidence-based Gene Panel Design

Session Chair: Mark Kiel, Genomenon, Inc.

Call for Oncologists to Learn About Precision Medicine

Session Chair: Vincent Miller, Foundation Medicine

Infrastructure and Computational Tools in Support of Research and Genomic Medicine

Session Chair: Elaine R. Mardis, Nationwide Children’s Hospital

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost

Session Chair: Stuart Goldberg, Cota Healthcare Inc.

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role

Session Chair: Chris Cournoyer, N-of-One

Accelerating Clinical Trials Using Comprehensive Liquid Biopsy

Session Chair: Daniel Simon, Guardant Health

Why Subsets are the Practice

Session Chair: Scott Zeger, Johns Hopkins Bloomberg School of Public Health

Informed Health Decisions Through Creating a Learning Ecosystem

Session Chair: Kenneth J. Pienta, Johns Hopkins University

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Delivering Precision Oncology in the Genomics Era

Session Chair: Rebecca Brandes, Agilent

IT Solutions in Support of Molecular and Genetics Labs

Session Chair: Chris Callahan, Sunquest

Metabolomics and its Role in Precision Medicine

Session Chair: John Ryals, Metabolon

Status Quo of Genome Sequencing in Cancer & Beyond

Session Chair: Charles M. Perou, GeneCentric Diagnostics

An Update on All of Us (PMI)

Session Chair: Geoffrey Ginsburg, Duke University School of Medicine

Human Genomics is Fueling Drug Discovery

Session Chair: Rick Dewey, Regeneron Genetics Center

The Value of Data Sharing

Session Chair: Kathy Giusti, Multiple Myeloma Research Foundation

Reforming Clinical Trials

Session Chair: Janet Woodcock, FDA

Data Science to Advance Precision Medicine

Session Chair: Eric Schadt, Icahn School of Medicine

Why Patient Engagement is Important

Session Chair: Frank Ingari, CureForward

Approaches towards Understanding and Enhancing Human Longevity

Session Chair: Brad Perkins, Human Longevity

Leaders in Academia and Industry to Foster Biotechnology

Session Chair: Ralph Snyderman, Duke University

Genomics & Precision Medicine in the “Real World”

Session Chair: Jonathan S. Berg, UNC-Chapel Hill

Single Cell Genomics: Emerging Applications

Session Chair: John Mikszta, BD Technologies

New Trends and Emerging Technologies

Session Chair: Mark Levin, Third Rock Ventures

Reimbursements – The Payor Perspective

Session Chair: Lee Newcomer, UnitedHealthcare

Novel Approaches to Infectious Disease Diagnosis

Session Chair: Christopher W. Woods, Duke University

Mobile Health is Changing Healthcare

Session Chair: Eric Perakslis, Takeda

Liquid Biopsy is Propelling Cancer Diagnostics Research

Session Chair: John Beeler, Inivata

The Role of the Human Microbiome

Session Chair: Lawrence David, Duke University

CRISPR – The Genome Engineering Revolution

Session Chair: Charles Gersbach, Duke

Recent Developments in Cancer Immunology & Immunotherapy

Session Chair: Matthias Gromeier, Duke University Medical Center

Testimonials

“PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content. This is the Conference for entrepreneurs to meet payors, and for researchers to connect with service providers and for clinicians to hear from leading providers.”

Lee Hood, PhD, MD

President, Institute for Systems Biology

“PMWC provides a valuable insight for physicians and others who may be wondering how close we are getting to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.”

Peter Paul Yu, MD, FACP, FASCO

Immediate Past President, ASCO

“PMWC is a very well organized conference based in Silicon Valley that addresses all of the salient issues facing personalized medicine and offers emerging personalized medicine companies a chance to showcase their latest innovations, reminding us how exciting the field is.”

Ed Abrahams, PhD

President, PMC